Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 13 May 2026 for LifeMD, Inc..
Filing timeline
BuySaleAtul Kavthekar
Insider track record
Disclosed buys
2
Disclosed sells
2
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -82.3%Entry US$169.50 · Close at T+365 US$30.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Atul Kavthekar: trading record in brief
This profile gathers the share dealings of Atul Kavthekar across 3 companies, led by Diplomat Pharmacy, Inc., P3 Health Partners Inc. and LifeMD, Inc. Over a trading history stretching from 20 November 2017 to 11 May 2026, the count stands at 8 filings.
Both buying and selling appear: 2 purchases worth €72k, against 2 sales worth €11k. Purchases outweigh sales by €60k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants.
The record was last updated on 13 May 2026 with a share grant in LifeMD, Inc. The latest purchase dates back some time: it was published 1,257 days ago, on 16 May 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Atul Kavthekar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
337,500 shares0Common StockSEC:0000912282-26-000709:0
750,000 shares0Class A Common StockSEC:0001104659-23-097747:0
18,868 shares@ US$2.6499100.0% of flowClass A Common StockSEC:0001104659-23-061504:0
Canonical exit: 13 Aug 2023 (T+90)
901 shares@ US$5.8241.7% of flowCommon StockSEC:0001596771-19-000032:0
15,118 shares0Common StockSEC:0001596771-19-000026:0
1,265 shares@ US$5.8458.3% of flowCommon StockSEC:0001596771-19-000026:1
11,100 shares0Common StockSEC:0001596771-18-000037:0
2,000 shares@ US$15.0069.6% of flowCommon StockSEC:0001703619-17-000001:0
Canonical exit: 18 Feb 2018 (T+90)
8 of 8 declarations
